Cost-effectiveness of radiofrequency echographic multi-spectrometry for the diagnosis of osteoporosis in the United States.

Despite uncertainty in the expected population reach, the potential benefits may be significant, including the prevention of at least 100 000 fractures and 43 000 QALYs over a lifetime under real-world medication adherence, assuming that 5% of women at HR and VHR of fractures are diagnosed and treated, and that REMS effectively detects all patients with osteoporosis.

also in 13,097 other papers